1 Good Clinical Data For SRF388, An Innovative Lung Cancer Drug, With Patients Stable For Oct 03, 2024
2 Study Shows Drug Halves Recurrence Rate In Patients With Early-Stage EGFR-Mutated Lung Cancer! Sep 21, 2024
3 Over 30% Of Tumours In Advanced Lung Cancer Patients In Remission With Frontier Drug Teliso-V In Combination With Troche! Aug 15, 2024
4 More Significant Survival Benefit For Non-Small Cell Lung Cancer Patients Under 55 Years Of Age, Also Using Immunotherapy! Aug 05, 2024
6 J Thorac Oncol: Survival Differences In Lung Cancer Patients By Gender And The Impact Of Prognostic Factors On Them Aug 17, 2023
Read More Apparatus New Lymphoma Drug Approved! Half Of The Patients Had Significant Tumour Regression Nov 21, 2024
Read More Apparatus FDI World Dental Federation Launches Toolkit To Make Dentistry More Sustainable Nov 20, 2024
